Home/Character Biosciences/Robert Kim, MD, MBA
RK

Robert Kim, MD, MBA

Chief Medical Officer

Character Biosciences

Roles

Chief Medical OfficeratCharacter Biosciences
Chief Medical Officerat4D Molecular Therapeutics

Character Biosciences Pipeline

DrugIndicationPhase
CTX203High risk intermediate AMD (dry AMD)Phase 1
CTX114Geographic Atrophy (secondary to AMD)Phase 1
Undisclosed AMD ProgramAge-Related Macular Degeneration (AMD)Research
Undisclosed POAG ProgramPrimary Open-Angle Glaucoma (POAG)Research